| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3K | — | +0.0% |
| R&D Expense | $445K | -2.0% | +6.6% |
| SG&A Expense | $296K | -15.2% | +157.4% |
| Operating Income | -$1.1M | +7.4% | +11.3% |
| Pre-tax Income | -$1.2M | +17.5% | +19.3% |
| Net Income | -$1.2M | +18.8% | +20.1% |
| EPS (Basic) | -$0.07 | +12.5% | +46.2% |
| EPS (Diluted) | -$0.07 | +12.5% | +46.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $644K | +33.0% | +727.9% |
| Total Assets | $75.9M | -0.0% | +27.0% |
| Current Liabilities | $902K | -10.4% | +1.5% |
| Total Liabilities | $11.1M | -1.0% | +1149.5% |
| Stockholders' Equity | $64.8M | +0.2% | +10.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | — |
| Capital Expenditures | $20K | — | — |
| Investing Cash Flow | -$12K | — | — |
| Financing Cash Flow | $3.8M | — | — |
| Free Cash Flow | -$3.7M | — | — |